Boehringer Ingelheim
CT · 12 filings, 2025
What the money shows
Boehringer Ingelheim reported $3.7M in federal lobbying for 2025 across 12 filings. The filings name 3 lobbying firms, led by Boehringer Ingelheim USA Corporation Formerly Reported AS Boehringer Ingelheim Pharmaceuticals and Monument Advocacy. The matched PAC file shows $5,000 to 0 lawmakers. The filing text lists 6 issue areas.
Sources: Senate LDA · FEC
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. via Wikipedia ↗
1Lobbies on
Its filings list: Budget/Appropriations · Animals · Agriculture · Health Issues · Medicare/Medicaid · Pharmacy
2Through these firms · 3
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- S 5240A bill to amend the Federal Crop Insurance Reform and Department of Agriculture Reorganization Act of 1994…
4And its PAC funds these lawmakers · 1
No republicans on file.